Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Dolores Edo Solsona

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 5, 2020
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseasesMaría Dolores Edo-Solsona, Isidro Vitoria-Miñana, José Luis Poveda-Andrés
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 26, 2023
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy ServicesMaría José Company Albir, José Luis Poveda Andrés, María Dolores Edo Solsona
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 26, 2023
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy ServicesMaría José Company Albir, José Luis Poveda Andrés, María Dolores Edo Solsona
Patient Preference and Adherence|March 11, 2017
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart<sup>®</sup> in patients with multiple sclerosisMaría Dolores Edo Solsona, Emilio Monte Boquet, Bonaventura Casanova Estruch, et al.
Clinical Neuropharmacology|May 18, 2012
Lithium citrate as treatment of Canavan diseaseMaría Dolores Edo Solsona, Laura Lorente Fernández, Emilio Monte Boquet, et al.
Frontiers in Pharmacology|January 5, 2026
Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug developmentNuria Gómez-Cebrián, María Chovi Trull, Elena Gras-Colomer, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 6, 2025
[Translated article] OrPhar-SEFH 2024-2027 Strategic PlanMónica Climente Martí, María Dolores Edo Solsona, María Reyes Abad Sazatornil, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 3, 2025
OrPhar-SEFH 2024-2027 Strategic PlanMónica Climente Martí, María Dolores Edo Solsona, María Reyes Abad Sazatornil, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|January 5, 2020
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseasesMaría Dolores Edo-Solsona, Isidro Vitoria-Miñana, José Luis Poveda-Andrés
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 26, 2023
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy ServicesMaría José Company Albir, José Luis Poveda Andrés, María Dolores Edo Solsona
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 26, 2023
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy ServicesMaría José Company Albir, José Luis Poveda Andrés, María Dolores Edo Solsona
Patient Preference and Adherence|March 11, 2017
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart<sup>®</sup> in patients with multiple sclerosisMaría Dolores Edo Solsona, Emilio Monte Boquet, Bonaventura Casanova Estruch, et al.
Clinical Neuropharmacology|May 18, 2012
Lithium citrate as treatment of Canavan diseaseMaría Dolores Edo Solsona, Laura Lorente Fernández, Emilio Monte Boquet, et al.
Frontiers in Pharmacology|January 5, 2026
Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug developmentNuria Gómez-Cebrián, María Chovi Trull, Elena Gras-Colomer, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 6, 2025
[Translated article] OrPhar-SEFH 2024-2027 Strategic PlanMónica Climente Martí, María Dolores Edo Solsona, María Reyes Abad Sazatornil, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|April 3, 2025
OrPhar-SEFH 2024-2027 Strategic PlanMónica Climente Martí, María Dolores Edo Solsona, María Reyes Abad Sazatornil, et al.
Pageof 1